Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Kairos Pharma (KAPA) Net Margin (2024 - 2025)

Historic Net Margin for Kairos Pharma (KAPA) over the last 2 years, with Q1 2025 value amounting to 1.26%.

  • Kairos Pharma's Net Margin fell 18950100.0% to 1.26% in Q1 2025 from the same period last year, while for Jun 2025 it was 5.21%, marking a year-over-year change of. This contributed to the annual value of 3.01% for FY2024, which is 41839700.0% down from last year.
  • Per Kairos Pharma's latest filing, its Net Margin stood at 1.26% for Q1 2025, which was down 18950100.0% from 171.32% recorded in Q3 2024.
  • Over the past 5 years, Kairos Pharma's Net Margin peaked at 1950.0% during Q2 2024, and registered a low of 1.26% during Q1 2025.